ORBAX: Labelling Issue
Last updated
Summary
Product
ORBAX
Issue
Health products - Labelling
What to do
See instructions below.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
ORBAX |
ORBAX |
DIN 02237713 |
Tablet |
ORBIFLOXACIN 22.7 MG |
28010015 |
Issue
The lot number and/or expiration date may not appear on the affected lot label.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Healthcare establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Veterinary drugs
Companies
Merck Canada / Intervet Canada Corp.
16750 Route Transcanadienne, Kirkland QC H9H 4M7
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Identification number
RA-64053
Get notified
Receive notifications for new and updated recalls and alerts by category.